Current Medicare reimbursement for complex endovascular aortic repair is inadequate based on results from a multi-institutional cost analysis
Objective: Complex endovascular juxta-, para- and suprarenal abdominal aortic aneurysm repair (comEVAR) is frequently accomplished with commercially available fenestrated (FEVAR) devices or off-label use of aortoiliac devices with parallel branch stents (chEVAR). We sought to evaluate the implantable vascular device costs incurred with these procedures as compared with standard Medicare reimbursement to determine the financial viability of comEVAR in the modern era.
Source: European Journal of Vascular and Endovascular Surgery - Category: Surgery Authors: Clayton J. Brinster, Samuel R. Money, Aaron Hayson, Ren é Gurdian, Ross Milner, Kayla Polcari, Mark Asirwatham, Dean J. Arnaoutakis, Chong Li, Thomas Maldonado, Dillon Cheung, Andrew Meltzer Tags: Clinical research study Source Type: research
More News: Abdominal Aneurysm Repair | Abdominal Aortic Aneurysm | Aortic Aneurysm | Gastroschisis Repair | Medicare | Study | Surgery